The Latest Breaking News from FDA

Google Pixel Watch 3 vs. Samsung Galaxy Watch 7: Which Android smartwatch should you get? We have answers.

The pain and complications of shingles do not end with the episode, as a new study suggests that its impact could be long-term.

There's now an option to treat anaphylaxis via a nasal spray, rather than with an auto-injected medication.

Plus: A listener asks the editors about tariffs and subsidies in the manufacture of electric vehicles.

Blue-chip dividend stocks are of well-established companies offering steady income and financial stability. They are ideal for securing a resilient retirement portfolio, combining consistent dividends with potential capital appreciation. Thus, quality blue-chip dividend stocks Johnson & Johnson (JNJ), Coca-Cola (KO), and McDonald’s (MCD) could be ideal portfolio additions for retirement…

The FDA, which approved the protocols for the studies it now questions, is asking for an additional Phase 3 clinical trial, which would take years and millions of dollars.

The Food and Drug Administration declined to approve MDMA as the first psychedelic drug used to treat post-traumatic stress disorder.

The new treatment, a needle-free alternative, could be used for managing severe allergic responses in children and adults, weighing at least 66 pounds, the FDA said.

JD Vance supports state autonomy in abortion policy, advocating for varied regulations based on state decisions.